Laurus Labs quoted higher for the fourth straight day, surging 15% in this period after delivering record quarterly revenue ...

Motilal Oswal Financial Services expects the company's earnings to grow at a 24% compounded annual rate over FY26-28 ...

InCred wrote in its note that their estimates carry the mix decisively towards the high-margin CDMO business, thereby lifting ...

Laurus Labs reported a strong June-quarter performance, with net profit more than doubling and revenue rising 29% ...

Laurus Labs on Friday reported a 124.7% YoY surge in Q1 consolidated net profit at ₹361.99 crore, backed by 28.8% growth in ...

Motilal Oswal is bullish on Laurus Labs has recommended buy rating on the stock with a target price of Rs 1980 in its ...

Laurus Labs' EBITDA margin for the quarter expanded by over seven percentage points to 31.5% from 24.3% on a year-on-year ...

On its KRKA joint venture, the company said construction of the FDF manufacturing site is progressing as planned, with ...

Laurus Labs reports a 126% rise in Q1 net profit to ₹368 crore, driven by strong revenue growth and R&D investments.

Laurus Labs Ltd (BOM:540222) reports a 29% revenue increase, driven by strong CDMO performance, while planning significant CapEx to meet future demands.

The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...

Shares of Laurus Labs hit a record high post strong Q1 earnings on Friday. The stock hit a high of Rs 845.60 against the previous close of Rs 835.85 on BSE. Market cap of the firm stood at Rs 45,261 ...